![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Viveve Wins Approval for Viveve System in Mexico
Viveve Wins Approval for Viveve System in Mexico
October 19, 2017
Viveve Medical received approval from the Mexican regulatory authority, COFEPRIS, to market its Viveve System in the country.
The device is used for treatment of vaginal introital laxity after childbirth.
The Viveve System has been cleared in more than 50 countries. The company said it plans to submit an investigational device exemption to the FDA to conduct a pivotal trial.
Upcoming Events
-
21Oct